SlideShare a Scribd company logo
Treatment in children
Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account for
individual variation among patients and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It
is the responsibility of the treating physician, or health care provider, to determine the best course of treatment for the patient. Treat the
Pain and its partners assume no responsibility for any injury or damage to persons or property arising out of or related to any use of
these materials, or for any errors or omissions. Last updated on January 12, 2015
Objectives
• Review methods of assessing pain in children
• Discuss treatment options and dosing for children based on
the age of the child and their level of pain
2
Three ways to assess pain in children
• Ask the child: FACES scale
• Ask the parent or caregiver
– Ask about previous exposure to pain, verbal pain
indicators, usual behavior or temperament
• Observe the child: FLACC scale
• The child is the best person to report their pain
Children’s Palliative Care in Africa, 2009 3
Wong-Baker FACES scale
• Use in children who can talk (usually 3 years and older)
• Explain to the child that each face is for a person who feels
happy because he has no pain, or a little sad because he has a
little pain, or very sad because he has a lot of pain
• Ask the child to pick one face that best describes his or her
current pain intensity
• Record the number of the pain level that the child reports to
make treatment decisions, follow-up, and compare between
examinations
Palliative Care for HIV/AIDS and Cancer Patients in Vietnam, Basic Training Curriculum: Harvard Medical School, Centre for
Palliative Care (2007) 4
FLACC scale
ICPCN (2009): Adapted from Merkel et al 5
• Use in children less than 3 years of age or older children who can’t talk
• Use it like an APGAR (Appearance, Pulse, Grimace, Activity, Respiration) score,
arriving at a score out of 10
Practice using FLACC scale
• Samuel is 18 months old. You observe that he is withdrawn,
kicking his legs, and squirming. His is constantly crying or
screaming, but is calmed down by breastfeeding.
6
Category Score
Face
Legs
Activity
Cry
Consolability
Total
Score
1
Score
1
2
Score
1
2
1
Score
1
2
1
2
Score
1
2
1
2
1
Score
1
2
1
2
1
7
Practice using FLACC scale
• Samuel is 18 months old. You observe that he is withdrawn,
kicking his legs, and squirming. His is constantly crying or
screaming, but is calmed down by breastfeeding.
7
Category Score
Face
Legs
Activity
Cry
Consolability
Total
Score
1
Score
1
2
Score
1
2
1
Score
1
2
1
2
Score
1
2
1
2
1
Score
1
2
1
2
1
7
8
Mild pain
Moderate or
Severe pain
Step 1
Non-opioid
Step 2
Strong opioid
+/- adjuvant
+/- non-opioid
+/- adjuvant
Consider prophylactic laxatives
to avoid constipation
Step up if
pain persists
or increases
Non-opioids Age>3 mos: ibuprofen or paracetamol (acetaminophen); Age<3 mos: paracetamol
Strong opioids morphine (medicine of choice) or fentanyl, oxycodone, hydromorphone, buprenorphine
Adjuvants antidepressant, anticonvulsant, antispasmodic, muscle relaxant, bisphosphonate, or
corticosteroid
Combining an opioid and non-opioid is effective, but do not combine drugs of the same class.
Time doses based on drug half-life (“dose by the clock”); do not wait for pain to recur
Ref: Adapted by Treat the Pain from World Health Organization http://www.who.int/cancer/palliative/painladder/en/ (accessed 7 November 2013)
WHO Analgesic Ladder: Pediatric
8
WHO ladder: pediatric
• Recently updated guidelines from the World Health
Organization (WHO) recommend using a 2-step ladder which
does not include the rung for weak opioids
• Weak opioids are not recommended for use in children
– Codeine
• Safety and efficacy problems related to genetic
variability that affects metabolism
• Low analgesic effect in infants and young children
– Tramadol
• Data are lacking on safety and efficacy in children
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 9
Step 1: mild pain
• Paracetamol and ibuprofen are the only medicines in this step
– No other NSAIDs are recommended
• Infants <3 months old
– Only paracetamol is recommended
• Children >3 months old
– Paracetamol or ibuprofen can be used
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 10
Dosing of Step 1 analgesics
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 11
Medicine <1 month 1-3 months 3 months-12
years
Maximum daily
dose
Paracetamol 5-10mg/kg every
6-8 hours
10mg/kg every 4-
6 hours
10-15mg/kg every
4-6 hours (max 1g
at a time)
4 doses per day
Ibuprofen Not recommended 5-10mg/kg every
6-8 hours
40mg/kg/day
* Children with poor nutritional state may be more susceptible to toxicity at standard doses
Step 2: moderate or severe pain
“There is no other class of medicines than strong opioids that is
effective in the treatment of moderate and severe pain.
Therefore, strong opioids are an essential element in pain
management.”
World Health Organization
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 12
Step 2: moderate or severe pain
• Morphine is the “medicine of choice”
– Alternatives can be used if a child experiences intolerable
side-effects
• As with adults, there is no maximum dose for opioids
– Titrate upward to find the dose that relieves pain with
tolerable side-effects
• Constipation is a common side effect, and all children taking
opioids should also take a stimulant laxative and a stool
softener
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 13
Starting dose for opioid-naïve neonates
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 14
Medicine Route Starting dose
Morphine IV/Sc injection 25-50mcg/kg every 6 hours
IV infusion Initial IV dose 25-50mcg/kg, then 5-10mcg/kg/hour
100mcg/kg every 4 or 6 hours
Fentanyl IV injection 1-2mcg/kg every 2 to 4 hours
IV infusion Initial IV dose 1-2mcg/kg, then 0.5-1mcg/kg/hour
* Administer IV morphine slowly over at least 5 minutes
* IV doses are based on acute pain management and sedation. Lower doses are required for non-ventilated
neonates
* Administer IV fentanyl slowly over 3-5 minutes
Starting dose for opioid-naïve infants (1 mo-1 yr)
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 15
Medicine Route Starting dose
Morphine Oral (immediate release) 80-200mcg/kg every 4 hours
IV/Sc injection 1-6 months: 100mcg/kg every 6 hours
6-12 months: 100mcg/kg every 4 hours
(max 2.5mg/dose)
IV infusion 1-6 months: Initial IV dose: 50mcg/kg, then:
10-30mcg/kg/hour
6-12 months: Initial IV dose: 100-200mcg/kg
then: 20-30mcg/kg/hour
Sc infusion 1-3 months: 10mcg/kg/hour
3-12 months: 20mcg/kg/hour
* Administer IV morphine slowly over at least 5 minutes
Starting dose for opioid-naïve infants (1 mo-1 yr)
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 16
Medicine Route Starting dose
Fentanyl IV injection 1-2mcg/kg every 2 to 4 hours
IV infusion Initial IV dose 1-2mcg/kg, then 0.5-
1mcg/kg/hour
Oxycodone Oral (immediate release) 50-125mcg/kg every 4 hours
* IV doses of fentanyl are based on acute pain management and sedation dosing information
Starting doses for opioid-naïve children (1-12 yrs)
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 17
Medicine Route Starting dose
Morphine Oral (immediate release) 1-2 years: 200-400mcg/kg every 4
hours
2-12 years: 200-500mcg/kg every 4
hours (max 5mg)
Oral (prolonged release) 200-800 mcg/kg every 12 hours
IV/Sc injection 1-2 years: 100mcg/kg every 4 hours
2-12 years: 100-200mcg/kg every 4
hours (max 2.5mg)
IV infusion Initial IV dose: 100-200mcg/kg, then
20-30 mcg/kg/hour
Sc infusion 20mcg/kg/hour
* Administer IV morphine slowly over at least 5 minutes
Starting doses for opioid-naïve children (1-12 yrs)
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 18
Medicine Route Starting dose
Fentanyl IV injection 1-2mcg/kg, repeated every 30-60 minutes
IV infusion Initial IV dose 1-2mcg/kg, then 1mcg/kg/hour
Hydromorphone Oral (immediate release) 30-80mcg/kg/hour every 3 to 4 hours (max 2mg/dose)
IV/Sc injection 15mcg/kg every 3 to 6 hours
Methadone Oral (immediate release) 100-200mcg/kg every 4 hours for the first 2-3 doses, then
every 6 to 12 hours (max 5mg/dose initially)
IV/Sc injection
Oxycodone Oral (immediate release) 125-200 mcg/kg every 4 hours (max 5mg/dose)
Oral (slow release) 5mg every 12 hours
* Administer IV fentanyl slowly over 3-5 minutes
* Hydromorphone is a potent opioid and significant differences exist between oral and intravenous dosing. Use extreme
caution when converting from one route to another. In converting from parenteral to oral hydromorphone, doses may
need to be titrated up to 5 times the IV dose. Administer IV hydromorphone slowly over 2-3 minutes
* Due to the complex nature and wide inter-individual variation in pharmacokinetics, methadone should only be
commenced by experienced practitioners
These opioids are more complex and should be started by an experienced provider
General principles
• Dose at regular intervals
– Medicines should always be given on a regular schedule and not
“as needed”, except for rescue doses
• Use the appropriate route of administration
– Medicines should be given by the simplest, most effective, and
least painful route
• Oral is preferred
• IV or subcutaneous, rectal, or transdermal are alternatives
when oral is not feasible
• IM is discouraged because it is painful
• Adapt treatment to the individual child
– Titrate to get to the correct dose
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 19
Side effects of opioids
Opioids are generally well-tolerated
• Mild sedation for first 48 hours is normal while child catches
up on sleep
• Constipation: treat with laxatives
• Pruritis: treat with topical treatments (calamine or
hydrocortizone) or oral antihistamines
• Urinary retention: treat with carbachol or bethanechol;
catheterization may be required
Children’s Palliative Care in Africa, Amery (2009) 20
Co-analgesia in children
• The WHO does not recommend corticosteroids or
biphosphonates to treat pain in children
• Neuropathic pain in children
– Consult an expert
– WHO guidance in this area is limited due to lack of
evidence
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. WHO (2012) 21
Procedural pain management principles
• Avoid non-necessary procedures
• Prepare for the procedure
• Involve the child and family
• Encourage the parents to be helpful and supportive
• Carry out procedures in child-friendly area away from the bed
• Use non-pharmacological and pharmacological interventions
to manage pain and anxiety
• After completing the procedure, congratulate the child and
instill a sense of achievement
Children’s Palliative Care in Africa, Amery (2009) 22
Procedural pain management
Drugs to use
• Topical anaesthetic agents (EMLA cream)
• Local anaesthetic: S/c lidocaine (make sure it is at body
temperature and buffer with sodium bicarbonate to reduce
pain of administration)
• If anxiety, rather than pain, is the issue: sedate with
benzodiazepine, pedichloryal (50-100mg/kg by mouth) or
promethizine (5mg/kg by mouth)
• If pain is the issue: use opioids in treatment doses
Children’s Palliative Care in Africa, Amery (2009) 23
Take home messages
• Pain in children can be assessed using observation and easy
tools
• Children as young as 3 years old can indicate their severity of
the pain
• For children, the WHO analgesic ladder is 2 steps
24
References
• African Palliative Care Association. Beating Pain: a pocketguide for pain management in Africa, 2nd
Ed. [Internet]. 2012. Available from:
http://www.africanpalliativecare.org/images/stories/pdf/beating_pain.pdf
• African Palliative Care Association. Using opioids to manage pain: a pocket guide for health
professionals in Africa [Internet]. 2010. Available from:
http://www.africanpalliativecare.org/images/stories/pdf/using_opiods.pdf
• Amery J, editor. Children’s Palliative Care in Africa [Internet]. 2009. Available from:
http://www.icpcn.org/wp-content/uploads/2013/08/Childrens-Palliative-Care-in-Africa-Full-
Text.pdf
• Kopf A, Patel N, editors. Guide to Pain Management in Low-Resource Settings [Internet]. 2010.
Available from: http://www.iasp-
pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Guide_to_Pain_Management_in_
Low-Resource_Settings.pdf
• The Palliative Care Association of Uganda and the Uganda Ministry of Health. Introductory Palliative
Care Course for Healthcare Professionals. 2013.
• World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in
children with medical illnesses [Internet]. 2012. Available from:
http://www.who.int/medicines/areas/quality_safety/guide_perspainchild/en/
25

More Related Content

Similar to 8. Treatment in Children (4).pptx

Paracetamol 30
Paracetamol 30Paracetamol 30
Paracetamol 30
Nuthan DeSouza
 
The Drug Exposed Neonate; Now What?
The Drug Exposed Neonate; Now What?The Drug Exposed Neonate; Now What?
The Drug Exposed Neonate; Now What?
ChildrensMercyKC
 
Intranasal Midazolam
Intranasal MidazolamIntranasal Midazolam
Intranasal Midazolam
Md Rabiul Alam
 
4. WHO analgesic ladder.pptx
4. WHO analgesic ladder.pptx4. WHO analgesic ladder.pptx
4. WHO analgesic ladder.pptx
JohnPaul474023
 
Rx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptxRx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptx
Mohammed Alhayani
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugs
drswarupa
 
hormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdfhormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdf
AderawAlemie
 
Neonatal abstinence syndrome
Neonatal abstinence syndromeNeonatal abstinence syndrome
Neonatal abstinence syndrome
Lazoi Lifecare Private Limited
 
General Anesthesia in Pediatric Dentistry
General Anesthesia in Pediatric Dentistry General Anesthesia in Pediatric Dentistry
General Anesthesia in Pediatric Dentistry
Jaya sri
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
CONSULTANT IN OBGYN, ODISHA ,INDIA
 
Nice bites-no-107-acute-resp-tract-infections-may-2018--1
Nice bites-no-107-acute-resp-tract-infections-may-2018--1Nice bites-no-107-acute-resp-tract-infections-may-2018--1
Nice bites-no-107-acute-resp-tract-infections-may-2018--1
juan luis delgadoestévez
 
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptxCommon Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
Thivyah Ahilan
 
Pediatric pain management
Pediatric pain managementPediatric pain management
Pediatric pain management
mohwily
 
Workflow1
Workflow1Workflow1
Workflow1
Lars Lindahl
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
Varsha Shah
 
Breakout C1 Franklin TFME
Breakout C1 Franklin TFMEBreakout C1 Franklin TFME
Breakout C1 Franklin TFME
The Foundation for Medical Excellence
 

Similar to 8. Treatment in Children (4).pptx (20)

Paracetamol 30
Paracetamol 30Paracetamol 30
Paracetamol 30
 
The Drug Exposed Neonate; Now What?
The Drug Exposed Neonate; Now What?The Drug Exposed Neonate; Now What?
The Drug Exposed Neonate; Now What?
 
Intranasal Midazolam
Intranasal MidazolamIntranasal Midazolam
Intranasal Midazolam
 
Agmnt cfalosn
Agmnt cfalosnAgmnt cfalosn
Agmnt cfalosn
 
OTP 2.pptx
OTP 2.pptxOTP 2.pptx
OTP 2.pptx
 
4. WHO analgesic ladder.pptx
4. WHO analgesic ladder.pptx4. WHO analgesic ladder.pptx
4. WHO analgesic ladder.pptx
 
Rx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptxRx in Pediatric dentistry.pptx
Rx in Pediatric dentistry.pptx
 
Periset.ppt
Periset.pptPeriset.ppt
Periset.ppt
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugs
 
hormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdfhormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdf
 
Neonatal abstinence syndrome
Neonatal abstinence syndromeNeonatal abstinence syndrome
Neonatal abstinence syndrome
 
General Anesthesia in Pediatric Dentistry
General Anesthesia in Pediatric Dentistry General Anesthesia in Pediatric Dentistry
General Anesthesia in Pediatric Dentistry
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
 
Nice bites-no-107-acute-resp-tract-infections-may-2018--1
Nice bites-no-107-acute-resp-tract-infections-may-2018--1Nice bites-no-107-acute-resp-tract-infections-may-2018--1
Nice bites-no-107-acute-resp-tract-infections-may-2018--1
 
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptxCommon Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
Common Acute Pediatric Urgent Issues Encountered in Primary Care Settings.pptx
 
Pediatric pain management
Pediatric pain managementPediatric pain management
Pediatric pain management
 
Workflow1
Workflow1Workflow1
Workflow1
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
 
Presentation1
Presentation1Presentation1
Presentation1
 
Breakout C1 Franklin TFME
Breakout C1 Franklin TFMEBreakout C1 Franklin TFME
Breakout C1 Franklin TFME
 

More from tesfkeb

10 minute- Contributions of leg length.pptx
10 minute- Contributions of leg length.pptx10 minute- Contributions of leg length.pptx
10 minute- Contributions of leg length.pptx
tesfkeb
 
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptxStaging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
tesfkeb
 
Case 8.pptx
Case 8.pptxCase 8.pptx
Case 8.pptx
tesfkeb
 
Intervertebral disc..tesf.pptx
Intervertebral disc..tesf.pptxIntervertebral disc..tesf.pptx
Intervertebral disc..tesf.pptx
tesfkeb
 
Preoperative medication management seminar.pptx
Preoperative medication management seminar.pptxPreoperative medication management seminar.pptx
Preoperative medication management seminar.pptx
tesfkeb
 
pre op care seminar.pptx
pre op care seminar.pptxpre op care seminar.pptx
pre op care seminar.pptx
tesfkeb
 
Extensor compartment of the hand..tesf.pptx
Extensor compartment of the hand..tesf.pptxExtensor compartment of the hand..tesf.pptx
Extensor compartment of the hand..tesf.pptx
tesfkeb
 
15. Labour pain Edt 7th.ppt
15. Labour pain Edt 7th.ppt15. Labour pain Edt 7th.ppt
15. Labour pain Edt 7th.ppt
tesfkeb
 
14. Burn Pain_Edt 7th.ppt
14. Burn Pain_Edt 7th.ppt14. Burn Pain_Edt 7th.ppt
14. Burn Pain_Edt 7th.ppt
tesfkeb
 
Palliative Care Emergencies.pptx
Palliative Care Emergencies.pptxPalliative Care Emergencies.pptx
Palliative Care Emergencies.pptx
tesfkeb
 
History of Palliative Care.pptx
History of Palliative Care.pptxHistory of Palliative Care.pptx
History of Palliative Care.pptx
tesfkeb
 
7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx
tesfkeb
 
6. Breakthrough, emergency, and incident pain (4).pptx
6. Breakthrough, emergency, and incident pain (4).pptx6. Breakthrough, emergency, and incident pain (4).pptx
6. Breakthrough, emergency, and incident pain (4).pptx
tesfkeb
 
5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx
tesfkeb
 
2. Mechanism of pain.pptx
2. Mechanism of pain.pptx2. Mechanism of pain.pptx
2. Mechanism of pain.pptx
tesfkeb
 
Lec AKI.ppt
Lec AKI.pptLec AKI.ppt
Lec AKI.ppt
tesfkeb
 
17. Blood transfusion.pptx
17. Blood transfusion.pptx17. Blood transfusion.pptx
17. Blood transfusion.pptx
tesfkeb
 
28-2 homeostasis (1).ppt
28-2 homeostasis (1).ppt28-2 homeostasis (1).ppt
28-2 homeostasis (1).ppt
tesfkeb
 
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptxBiomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
tesfkeb
 
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptxUnit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
tesfkeb
 

More from tesfkeb (20)

10 minute- Contributions of leg length.pptx
10 minute- Contributions of leg length.pptx10 minute- Contributions of leg length.pptx
10 minute- Contributions of leg length.pptx
 
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptxStaging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
Staging_of_necrotizing_fasciitis_based_on_the_evolving_cutaneous.pptx
 
Case 8.pptx
Case 8.pptxCase 8.pptx
Case 8.pptx
 
Intervertebral disc..tesf.pptx
Intervertebral disc..tesf.pptxIntervertebral disc..tesf.pptx
Intervertebral disc..tesf.pptx
 
Preoperative medication management seminar.pptx
Preoperative medication management seminar.pptxPreoperative medication management seminar.pptx
Preoperative medication management seminar.pptx
 
pre op care seminar.pptx
pre op care seminar.pptxpre op care seminar.pptx
pre op care seminar.pptx
 
Extensor compartment of the hand..tesf.pptx
Extensor compartment of the hand..tesf.pptxExtensor compartment of the hand..tesf.pptx
Extensor compartment of the hand..tesf.pptx
 
15. Labour pain Edt 7th.ppt
15. Labour pain Edt 7th.ppt15. Labour pain Edt 7th.ppt
15. Labour pain Edt 7th.ppt
 
14. Burn Pain_Edt 7th.ppt
14. Burn Pain_Edt 7th.ppt14. Burn Pain_Edt 7th.ppt
14. Burn Pain_Edt 7th.ppt
 
Palliative Care Emergencies.pptx
Palliative Care Emergencies.pptxPalliative Care Emergencies.pptx
Palliative Care Emergencies.pptx
 
History of Palliative Care.pptx
History of Palliative Care.pptxHistory of Palliative Care.pptx
History of Palliative Care.pptx
 
7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx
 
6. Breakthrough, emergency, and incident pain (4).pptx
6. Breakthrough, emergency, and incident pain (4).pptx6. Breakthrough, emergency, and incident pain (4).pptx
6. Breakthrough, emergency, and incident pain (4).pptx
 
5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx
 
2. Mechanism of pain.pptx
2. Mechanism of pain.pptx2. Mechanism of pain.pptx
2. Mechanism of pain.pptx
 
Lec AKI.ppt
Lec AKI.pptLec AKI.ppt
Lec AKI.ppt
 
17. Blood transfusion.pptx
17. Blood transfusion.pptx17. Blood transfusion.pptx
17. Blood transfusion.pptx
 
28-2 homeostasis (1).ppt
28-2 homeostasis (1).ppt28-2 homeostasis (1).ppt
28-2 homeostasis (1).ppt
 
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptxBiomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
Biomechanics of Fracture and Fixation Justice 10.3.2005 (1).pptx
 
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptxUnit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
Unit_8_Data_processing,_analysis_and_presentation_and_Application (1).pptx
 

Recently uploaded

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

8. Treatment in Children (4).pptx

  • 1. Treatment in children Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account for individual variation among patients and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It is the responsibility of the treating physician, or health care provider, to determine the best course of treatment for the patient. Treat the Pain and its partners assume no responsibility for any injury or damage to persons or property arising out of or related to any use of these materials, or for any errors or omissions. Last updated on January 12, 2015
  • 2. Objectives • Review methods of assessing pain in children • Discuss treatment options and dosing for children based on the age of the child and their level of pain 2
  • 3. Three ways to assess pain in children • Ask the child: FACES scale • Ask the parent or caregiver – Ask about previous exposure to pain, verbal pain indicators, usual behavior or temperament • Observe the child: FLACC scale • The child is the best person to report their pain Children’s Palliative Care in Africa, 2009 3
  • 4. Wong-Baker FACES scale • Use in children who can talk (usually 3 years and older) • Explain to the child that each face is for a person who feels happy because he has no pain, or a little sad because he has a little pain, or very sad because he has a lot of pain • Ask the child to pick one face that best describes his or her current pain intensity • Record the number of the pain level that the child reports to make treatment decisions, follow-up, and compare between examinations Palliative Care for HIV/AIDS and Cancer Patients in Vietnam, Basic Training Curriculum: Harvard Medical School, Centre for Palliative Care (2007) 4
  • 5. FLACC scale ICPCN (2009): Adapted from Merkel et al 5 • Use in children less than 3 years of age or older children who can’t talk • Use it like an APGAR (Appearance, Pulse, Grimace, Activity, Respiration) score, arriving at a score out of 10
  • 6. Practice using FLACC scale • Samuel is 18 months old. You observe that he is withdrawn, kicking his legs, and squirming. His is constantly crying or screaming, but is calmed down by breastfeeding. 6 Category Score Face Legs Activity Cry Consolability Total Score 1 Score 1 2 Score 1 2 1 Score 1 2 1 2 Score 1 2 1 2 1 Score 1 2 1 2 1 7
  • 7. Practice using FLACC scale • Samuel is 18 months old. You observe that he is withdrawn, kicking his legs, and squirming. His is constantly crying or screaming, but is calmed down by breastfeeding. 7 Category Score Face Legs Activity Cry Consolability Total Score 1 Score 1 2 Score 1 2 1 Score 1 2 1 2 Score 1 2 1 2 1 Score 1 2 1 2 1 7
  • 8. 8 Mild pain Moderate or Severe pain Step 1 Non-opioid Step 2 Strong opioid +/- adjuvant +/- non-opioid +/- adjuvant Consider prophylactic laxatives to avoid constipation Step up if pain persists or increases Non-opioids Age>3 mos: ibuprofen or paracetamol (acetaminophen); Age<3 mos: paracetamol Strong opioids morphine (medicine of choice) or fentanyl, oxycodone, hydromorphone, buprenorphine Adjuvants antidepressant, anticonvulsant, antispasmodic, muscle relaxant, bisphosphonate, or corticosteroid Combining an opioid and non-opioid is effective, but do not combine drugs of the same class. Time doses based on drug half-life (“dose by the clock”); do not wait for pain to recur Ref: Adapted by Treat the Pain from World Health Organization http://www.who.int/cancer/palliative/painladder/en/ (accessed 7 November 2013) WHO Analgesic Ladder: Pediatric 8
  • 9. WHO ladder: pediatric • Recently updated guidelines from the World Health Organization (WHO) recommend using a 2-step ladder which does not include the rung for weak opioids • Weak opioids are not recommended for use in children – Codeine • Safety and efficacy problems related to genetic variability that affects metabolism • Low analgesic effect in infants and young children – Tramadol • Data are lacking on safety and efficacy in children WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 9
  • 10. Step 1: mild pain • Paracetamol and ibuprofen are the only medicines in this step – No other NSAIDs are recommended • Infants <3 months old – Only paracetamol is recommended • Children >3 months old – Paracetamol or ibuprofen can be used WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 10
  • 11. Dosing of Step 1 analgesics WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 11 Medicine <1 month 1-3 months 3 months-12 years Maximum daily dose Paracetamol 5-10mg/kg every 6-8 hours 10mg/kg every 4- 6 hours 10-15mg/kg every 4-6 hours (max 1g at a time) 4 doses per day Ibuprofen Not recommended 5-10mg/kg every 6-8 hours 40mg/kg/day * Children with poor nutritional state may be more susceptible to toxicity at standard doses
  • 12. Step 2: moderate or severe pain “There is no other class of medicines than strong opioids that is effective in the treatment of moderate and severe pain. Therefore, strong opioids are an essential element in pain management.” World Health Organization WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 12
  • 13. Step 2: moderate or severe pain • Morphine is the “medicine of choice” – Alternatives can be used if a child experiences intolerable side-effects • As with adults, there is no maximum dose for opioids – Titrate upward to find the dose that relieves pain with tolerable side-effects • Constipation is a common side effect, and all children taking opioids should also take a stimulant laxative and a stool softener WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 13
  • 14. Starting dose for opioid-naïve neonates WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 14 Medicine Route Starting dose Morphine IV/Sc injection 25-50mcg/kg every 6 hours IV infusion Initial IV dose 25-50mcg/kg, then 5-10mcg/kg/hour 100mcg/kg every 4 or 6 hours Fentanyl IV injection 1-2mcg/kg every 2 to 4 hours IV infusion Initial IV dose 1-2mcg/kg, then 0.5-1mcg/kg/hour * Administer IV morphine slowly over at least 5 minutes * IV doses are based on acute pain management and sedation. Lower doses are required for non-ventilated neonates * Administer IV fentanyl slowly over 3-5 minutes
  • 15. Starting dose for opioid-naïve infants (1 mo-1 yr) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 15 Medicine Route Starting dose Morphine Oral (immediate release) 80-200mcg/kg every 4 hours IV/Sc injection 1-6 months: 100mcg/kg every 6 hours 6-12 months: 100mcg/kg every 4 hours (max 2.5mg/dose) IV infusion 1-6 months: Initial IV dose: 50mcg/kg, then: 10-30mcg/kg/hour 6-12 months: Initial IV dose: 100-200mcg/kg then: 20-30mcg/kg/hour Sc infusion 1-3 months: 10mcg/kg/hour 3-12 months: 20mcg/kg/hour * Administer IV morphine slowly over at least 5 minutes
  • 16. Starting dose for opioid-naïve infants (1 mo-1 yr) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 16 Medicine Route Starting dose Fentanyl IV injection 1-2mcg/kg every 2 to 4 hours IV infusion Initial IV dose 1-2mcg/kg, then 0.5- 1mcg/kg/hour Oxycodone Oral (immediate release) 50-125mcg/kg every 4 hours * IV doses of fentanyl are based on acute pain management and sedation dosing information
  • 17. Starting doses for opioid-naïve children (1-12 yrs) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 17 Medicine Route Starting dose Morphine Oral (immediate release) 1-2 years: 200-400mcg/kg every 4 hours 2-12 years: 200-500mcg/kg every 4 hours (max 5mg) Oral (prolonged release) 200-800 mcg/kg every 12 hours IV/Sc injection 1-2 years: 100mcg/kg every 4 hours 2-12 years: 100-200mcg/kg every 4 hours (max 2.5mg) IV infusion Initial IV dose: 100-200mcg/kg, then 20-30 mcg/kg/hour Sc infusion 20mcg/kg/hour * Administer IV morphine slowly over at least 5 minutes
  • 18. Starting doses for opioid-naïve children (1-12 yrs) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 18 Medicine Route Starting dose Fentanyl IV injection 1-2mcg/kg, repeated every 30-60 minutes IV infusion Initial IV dose 1-2mcg/kg, then 1mcg/kg/hour Hydromorphone Oral (immediate release) 30-80mcg/kg/hour every 3 to 4 hours (max 2mg/dose) IV/Sc injection 15mcg/kg every 3 to 6 hours Methadone Oral (immediate release) 100-200mcg/kg every 4 hours for the first 2-3 doses, then every 6 to 12 hours (max 5mg/dose initially) IV/Sc injection Oxycodone Oral (immediate release) 125-200 mcg/kg every 4 hours (max 5mg/dose) Oral (slow release) 5mg every 12 hours * Administer IV fentanyl slowly over 3-5 minutes * Hydromorphone is a potent opioid and significant differences exist between oral and intravenous dosing. Use extreme caution when converting from one route to another. In converting from parenteral to oral hydromorphone, doses may need to be titrated up to 5 times the IV dose. Administer IV hydromorphone slowly over 2-3 minutes * Due to the complex nature and wide inter-individual variation in pharmacokinetics, methadone should only be commenced by experienced practitioners These opioids are more complex and should be started by an experienced provider
  • 19. General principles • Dose at regular intervals – Medicines should always be given on a regular schedule and not “as needed”, except for rescue doses • Use the appropriate route of administration – Medicines should be given by the simplest, most effective, and least painful route • Oral is preferred • IV or subcutaneous, rectal, or transdermal are alternatives when oral is not feasible • IM is discouraged because it is painful • Adapt treatment to the individual child – Titrate to get to the correct dose WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses, WHO (2012) 19
  • 20. Side effects of opioids Opioids are generally well-tolerated • Mild sedation for first 48 hours is normal while child catches up on sleep • Constipation: treat with laxatives • Pruritis: treat with topical treatments (calamine or hydrocortizone) or oral antihistamines • Urinary retention: treat with carbachol or bethanechol; catheterization may be required Children’s Palliative Care in Africa, Amery (2009) 20
  • 21. Co-analgesia in children • The WHO does not recommend corticosteroids or biphosphonates to treat pain in children • Neuropathic pain in children – Consult an expert – WHO guidance in this area is limited due to lack of evidence WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. WHO (2012) 21
  • 22. Procedural pain management principles • Avoid non-necessary procedures • Prepare for the procedure • Involve the child and family • Encourage the parents to be helpful and supportive • Carry out procedures in child-friendly area away from the bed • Use non-pharmacological and pharmacological interventions to manage pain and anxiety • After completing the procedure, congratulate the child and instill a sense of achievement Children’s Palliative Care in Africa, Amery (2009) 22
  • 23. Procedural pain management Drugs to use • Topical anaesthetic agents (EMLA cream) • Local anaesthetic: S/c lidocaine (make sure it is at body temperature and buffer with sodium bicarbonate to reduce pain of administration) • If anxiety, rather than pain, is the issue: sedate with benzodiazepine, pedichloryal (50-100mg/kg by mouth) or promethizine (5mg/kg by mouth) • If pain is the issue: use opioids in treatment doses Children’s Palliative Care in Africa, Amery (2009) 23
  • 24. Take home messages • Pain in children can be assessed using observation and easy tools • Children as young as 3 years old can indicate their severity of the pain • For children, the WHO analgesic ladder is 2 steps 24
  • 25. References • African Palliative Care Association. Beating Pain: a pocketguide for pain management in Africa, 2nd Ed. [Internet]. 2012. Available from: http://www.africanpalliativecare.org/images/stories/pdf/beating_pain.pdf • African Palliative Care Association. Using opioids to manage pain: a pocket guide for health professionals in Africa [Internet]. 2010. Available from: http://www.africanpalliativecare.org/images/stories/pdf/using_opiods.pdf • Amery J, editor. Children’s Palliative Care in Africa [Internet]. 2009. Available from: http://www.icpcn.org/wp-content/uploads/2013/08/Childrens-Palliative-Care-in-Africa-Full- Text.pdf • Kopf A, Patel N, editors. Guide to Pain Management in Low-Resource Settings [Internet]. 2010. Available from: http://www.iasp- pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Guide_to_Pain_Management_in_ Low-Resource_Settings.pdf • The Palliative Care Association of Uganda and the Uganda Ministry of Health. Introductory Palliative Care Course for Healthcare Professionals. 2013. • World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses [Internet]. 2012. Available from: http://www.who.int/medicines/areas/quality_safety/guide_perspainchild/en/ 25